
Researchers teamed up to develop a 'three in one' HIV treatment — and the NIH is throwing in $14.6M
The NIH is pitching $14.6 million into a “three for one” HIV research program led by USC and the Fred Hutchinson Cancer Research Center that aims to strike the need for daily medication — or even achieve a “home run” cure.
The five-year grant will back preclinical studies that combine gene editing with technology to improve bone marrow transplants. The potential therapy would engineer a patient’s own stem cells to fight HIV, and stimulate them to produce new immune cells once reintroduced to the patient.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.